Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Kjeld Schmiegelow, Ibrahim Al-Modhawi, Mette Klarskov Andersen, Mikael Berendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)6258-6259
Number of pages2
JournalBlood
Volume113
Issue number24
DOIs
StatePublished - Nov 18 2009

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Schmiegelow, K., Al-Modhawi, I., Andersen, M. K., Berendtz, M., Forestier, E., Hasle, H., Heyman, M., Kristinsson, J., Nersting, J., Nygaard, R., Svendsen, A. L., Vettenranta, K., & Weinshilboum, R. (2009). Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms? Blood, 113(24), 6258-6259. https://doi.org/10.1182/blood-2009-03-210195